Project Grant R01AG084563
Award Date
5/1/25
Completion Date
4/30/30
Dollars Obligated
$811K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $943,540 to the Dana-Farber Cancer Institute, Inc. (DFCI) to develop and evaluate the effectiveness of a Shared Decision Making (SDM) toolkit to support older breast cancer survivors in discontinuing surveillance mammography when the harms are likely to outweigh the benefits. The project aims to determine the effects of the SDM toolkit on mammography use, decision quality, and knowledge in...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides funding of $444,569 over a 2-year period from June 1, 2024 to May 31, 2026 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to develop more representative patient-derived models of hormone receptor positive (HR+) breast cancer, including those from underrepresented ethnicities. The award aims to expand the availability of these models and investigate therapeutic...
This federal Project Grant award, sponsored by the Department of Health and Human Services' National Institute on Aging under the Aging Research program (CFDA 93.866), provides $624,000.00 to the University of Texas Health Science Center at Houston to explore patient priorities-based breast cancer survivorship care for older women. The proposed project will use a patient priorities care framework to identify and align the survivorship care needs and preferences of older breast cancer survivors...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a 5-year, $242,956 research effort to improve shared decision-making for older adults with cognitive impairment, using Parkinson's disease patients with mild cognitive impairment as a model. The key objectives are to: 1) Adapt and refine a decision aid to address cognitive weaknesses for Parkinson's patients considering deep brain stimulation surgery, 2) Evaluate the feasibility,...
This federal Project Grant award of $684,333 from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), aims to evaluate whether patient and provider decision support that compares breast cancer and cardiovascular disease risk can improve the acceptance and uptake of chemoprevention among racially/ethnically diverse women at high risk for breast cancer. The key products and services to be delivered under this 5-year grant, which begins on...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Duke University aims to improve decision-making for older adults with melanoma. The $322,000 award, with a period of performance from September 2024 to August 2026, has two key objectives: Characterize the healthcare trajectories of older adults with melanoma to inform discussions about the goals and downsides of treatment within a "Better Conversations" shared decision-making...
This Project Grant award of $799,998, provided by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, supports research to evaluate the use and expenditures on low-quality breast cancer care in the Medicare program. The primary awardee, Georgetown University, will examine differences in the receipt of low-value breast cancer care across traditional Medicare (TM) and Medicare Advantage (MA) plans, including...
This federal Project Grant award of $308,000.00 from the National Institute on Aging's Aging Research program (CFDA 93.866) aims to develop a user-friendly shared decision-making (SDM) tool for surgeons to improve communication with frail older adult patients considering major colorectal surgery. The tool will be adapted from an existing SDM framework through a Delphi process with clinical experts and patient representatives, utilizing the RAND/UCLA Appropriateness Methodology. The adapted...
This $234,000 Project Grant awarded by the National Institute on Aging (part of the Department of Health and Human Services) under the Aging Research program (CFDA 93.866) aims to develop and pilot a patient decision aid to support shared decision-making between clinicians, patients, and families regarding pharmacologic therapies for dementia. The key products and services to be delivered under this 2-year award include: 1) conducting a qualitative needs assessment on decision-making needs for...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $388,750 to The Washington University in St. Louis to investigate the role of senescent cancer-associated fibroblasts (SenCAFs) in breast cancer progression. The research aims to: Determine the organ-specific effects of SenCAFs on metastatic breast cancer progression; Examine how SenCAFs impact extracellular matrix dynamics and tumor cell migration; and Evaluate the impact of SenCAFs...